secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2025-09-17T23:59:59+00:00
Accession:  0001437749-25-029285
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics enters $2M secured loan with B. Riley at 10% interest
------------------------------------------------------------------

- Agreement with B. Riley Commercial Capital for up to $2.0M secured term loan, maturing Sept 14, 2026 or upon qualified equity raise of $2.4M.
- Interest at 10% per annum; exit fee of $200K (10% of principal) due at maturity.
- Loan may convert into equity in connection with a qualified financing at the lead investor's price.
- Existing $2.0M loan from Banc of California (Pacific Western Bank) terminated and fully paid off.
- Proceeds for working capital and general corporate purposes; secured by substantially all personal property of company and subsidiary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774925029285/0001437749-25-029285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774925029285/ekso20250917_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-029285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer